Made-In-India Covid Vaccines In Yemen A "Game Changer": UN Official
NDTV
The AstraZeneca vaccines are licensed and manufactured by the Serum Institute of India and will enable health workers and other priority populations vulnerable to COVID-19 to be protected against the virus, it said.
The shipment of 360,000 Made-in-India COVID-19 vaccines that arrived in Yemen, as part of the first batch of 1.9 million doses it will receive throughout the year, is a "game changer" and a "milestone" in the fight against the pandemic in the country, health officials have said. Arrival in Aden. Made in India vaccines land in Yemen.#VaccineMaitripic.twitter.com/ISs2LgNOZ0 Yemen on Wednesday received 360,000 COVID-19 vaccine doses shipped via the COVAX Facility, a partnership between the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, UNICEF and the World Health Organization (WHO), UNICEF said in a statement. The AstraZeneca vaccines are licensed and manufactured by the Serum Institute of India and will enable health workers and other priority populations vulnerable to COVID-19 to be protected against the virus, it said. The 360,000 doses arrived with 13,000 safety boxes and 1,300,000 syringes that are critical for the safe and effective roll-out of the vaccination campaign. This first batch is part of 1.9 million doses that Yemen will initially receive throughout 2021.More Related News